Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Log out
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Agence Bibliographique de l Enseignement Superieur (ABES)

discontinuation

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)
Paul Emery, Gerd R Burmester, Esperanza Naredo, Yijie Zhou, Maja Hojnik, Philip G Conaghan

BMJ Open Feb 2018, 8 (2) e019007; DOI: 10.1136/bmjopen-2017-019007
Cross-sectional study on medicinal products without commercial interest (MPWCI) in the Spanish market
Emili Esteve Sala, Fátima Montes Barroso, Elvira Bel Prieto, Josep María Suñé Negre

BMJ Open Jan 2019, 9 (1) e023054; DOI: 10.1136/bmjopen-2018-023054
Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers
Marloes J Huijbers, Carolien Wentink, Esther Simons, Jan Spijker, Anne Speckens

BMJ Open Nov 2020, 10 (11) e039053; DOI: 10.1136/bmjopen-2020-039053
Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
Olivier Vittecoq, Sandra Desouches, Marie Kozyreff, Julia Nicolau, Sophie Pouplin, Pascal Rottenberg, Nicolas Sens, Thierry Lequerre, Gilles Avenel

BMJ Open Dec 2019, 9 (12) e031467; DOI: 10.1136/bmjopen-2019-031467
Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
Henk van der Worp, Petra Jellema, Ilse Hordijk, Yvonne Lisman-van Leeuwen, Lisa Korteschiel, Martijn G Steffens, Marco H Blanker

BMJ Open Nov 2019, 9 (11) e030405; DOI: 10.1136/bmjopen-2019-030405
Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK
Ana Ruigómez, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Luke Roberts, Samuel Fatoba, Oscar Fernandez, Luis Alberto García Rodríguez

BMJ Open Oct 2019, 9 (10) e031342; DOI: 10.1136/bmjopen-2019-031342
Patients who discontinued statin treatment: a protocol for cohort study using primary care data
Yana Vinogradova, Carol Coupland, Peter Brindle, Julia Hippisley-Cox

BMJ Open Oct 2015, 5 (10) e008701; DOI: 10.1136/bmjopen-2015-008701